News | EP Mapping and Imaging Systems | October 06, 2015

AcQMap System Shows Improved 3-D Mapping Over CT During AFib Ablation

Technology demonstrates higher resolution, faster mapping times during treatment of cardiac arrhythmias

Acutus Medical, AcQMap High Resolution Imaging and Mapping System, improvement over sCT

Image courtesy of Acutus Medical

October 6, 2015 — Acutus Medical, a global heart rhythm technology company, presented data that show the AcQMap High Resolution Imaging and Mapping System more rapidly and clearly maps atrial fibrillation (AF) than segmented computed tomography (sCT) mapping, the current standard for most AF ablation procedures.  The initial study findings were presented during an oral presentation at the 10th annual Heart Rhythm Congress held in Birmingham, United Kingdom, Oct. 4-7, 2015.

The abstract titled, “Novel Global Ultrasound Imaging And Continuous Dipole Density Mapping: Initial Findings In AF Patients” was presented by Patrick Heck, M.D., Ph.D, Papworth Hospital, Cambridge, UK. The study evaluated the difference in mapping clarity and detection time between the AcQMap System and sCT in six patients diagnosed with complex arrhythmias. The findings concluded that the AcQMap System reconstructed an image of the atrium at 4.1 times higher resolution than that of sCT. The System also detected the arrhythmia more quickly than sCT (4:07 minutes versus 6:39 minutes, respectively).

“These data underscore the potential advantage the AcQMap System can provide to electrophysiologists (EPs) during AF procedures compared to current standards of mapping technology,” said Heck.  “The image quality of the AcQMap System is unparalleled and allows EPs to see areas of the heart chamber we’ve never been able to visualize before. This is an impressive leap forward, truly opening the possibility to map AF with more precision to identify areas of interest as potential ablation targets.”

The AcQMap System can generate real-time ultrasound images of the heart chamber with quality equivalent to a CT or magnetic resonance image (MRI) in a matter of minutes. The system is the first and only to detect and display both the standard voltage-based maps as well as the higher resolution source charge (dipole density) maps through a proprietary algorithm. The result of combining highly accurate imaging with higher resolution mapping capabilities enables EPs to identify and locate the responsible charge for the arrhythmia, precisely target treatment areas and minimize unnecessary heart ablations.

For more information: www.acutusmedical.com

Related Content

Vagal Maneuvers With Supraventricular Tachycardia

Image courtesy of ACLS Certification Institute

Feature | EP Lab | December 05, 2018
Supraventricular tachycardia (SVT) is a common heart abnormality that presents as a fast heart rate. SVT is a generic...
Societies Publish New Guidance for Treatment of Slow, Irregular Heartbeats
News | EP Lab | November 09, 2018
The American College of Cardiology (ACC), the American Heart Association (AHA) and the Heart Rhythm Society (HRS)...
A view of the EPD Solutions catheter ablation system image guidance. It displays the catheter within a pre-acquired 3D segmented CT image. The D700 system provides a real-time lesion assessment tool that predicts transmurality and permanency of lesions, pre- and immediately post-ablation.

A view of the EPD Solutions catheter ablation system image guidance. It displays the catheter within a pre-acquired 3D segmented CT image. The D700 system provides a real-time lesion assessment tool that predicts transmurality and permanency of lesions, pre- and immediately post-ablation.

News | EP Lab | June 05, 2018
June 5, 2018 — Philips Healthcare has signed an agreement to acquire EPD Solutions, a provider of image-guidance in c
A recent study shows the Baylis NRG radiofrequency (RF) Transseptal puncture catheter has a lower incidence of embolism in EP cases.
News | EP Lab | May 21, 2018
May 21, 2018 — A recent study published in Heart and Vessels has found that the use of the Baylis Medical NR
Myocarditis is an Under-recognized Etiology of Symptomatic Premature Ventricular Arrhythmia (PVCs). #HRS #HRS2018
News | EP Lab | May 18, 2018
May 18, 2018 — A significant number of patients with symptomatic premature ventricular contractions (PVCs) have under
Novel Antibiotics Can Help Lower EP Device Infection Rates. Pictured here is an ICD. Implantation of pacemakers, ICDs and the related cardiac leads opens patients to infection risk.

Implantation of pacemakers, ICDs and the related cardiac leads opens patients to infection risk.

News | EP Lab | May 17, 2018
May 10, 2018 – A new study is the first to test the clinical effectiveness of incremental peri-operative antibiotics
The Apple Watch Series 2, Samsung Galaxy Gear S3 and the Fitbit Charge 2 were all able to properly diagnose the very rapid heart beats involved in  paroxysmal supraventricular tachycardia (PSVT). #HRS2018

The Apple Watch Series 2, Samsung Galaxy Gear S3 and the Fitbit Charge 2 were all able to properly diagnose the very rapid heart beats involved in  paroxysmal supraventricular tachycardia (PSVT).  

News | EP Lab | May 16, 2018
May 16, 2018 — A new study is the first to validate the accuracy of wrist-worn wearable devices in measuring induced
LivaNova Completes Sale of Cardiac Rhythm Management (CRM - electrophysiology) Business to MicroPort Scientific
News | EP Lab | April 30, 2018
April 30, 2018 — LivaNova announced it completed the sale of its cardiac rhythm management (CRM) business to MicroPor
Overlay Init